BABA
Alibaba Group Holding Limited
BABA's outlook is improving, though it still trails on the overall score.
LEA
Lear Corporation
LEA has the edge over BABA overall, supported by stronger valuation and stronger fundamentals.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
LEA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Healthy |
LEA's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
LEA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 6.8x | $109 | — |
| Current | 9.5x | $109 | — |
| Cheap | 11x | $121 | +12% |
| Fair | 14x | $164 | +51% |
| Expensive | 38x | $434 | +300% |
Historical ranges are pointers, not guarantees.
LEA has the edge over BABA in the historical PE scenario, which offers more potential upside but is not a forecast.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over LEA on the outlook, with more favorable revenue expectations.
LEA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect LEA's earnings to grow and its profitability to improve, with its revenue holding steady.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over LEA on earnings, with more consistent year-over-year improvement.
LEA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $15.95 | +39% |
| Q3 2026 | $11.45 | +39% |
| Q2 2026 | $10.73 | +25% |
| Q1 2026 | $10.00 | +17% |
| Q4 2025 | $8.15 | -9.1% |
| Q3 2025 | $8.21 | -14% |
| Q2 2025 | $8.60 | -8% |
| Q1 2025 | $8.56 | -6.7% |
| Q4 2024 | $8.97 | -7.3% |
LEA earned $11.45 per share over the past year, up 39% from the year before.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over LEA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over LEA on profitability, with a higher operating margin.
LEA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.8B | +1.6% |
| Q2 2026 | $6.2B | +3% |
| Q1 2026 | $5.8B | +4.7% |
| Q4 2025 | $6B | +4.8% |
| Q3 2025 | $5.7B | +1.7% |
| Q2 2025 | $6B | +0.3% |
| Q1 2025 | $5.6B | -7.2% |
| Q4 2024 | $5.7B | -2.2% |
LEA's revenue grew through 2023 and has held roughly level since: $5.8B last quarter, up 1.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.4% | 0 points |
| Q2 2026 | 4.3% | +0.2 points |
| Q1 2026 | 4.4% | +1.1 points |
| Q4 2025 | 2.6% | -1.1 points |
| Q3 2025 | 3.4% | -0.6 points |
| Q2 2025 | 4.1% | -0.2 points |
| Q1 2025 | 3.3% | 0 points |
| Q4 2024 | 3.7% | -0.1 points |
LEA's operating margin was 3.4% last quarter, about level with the same quarter a year ago.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
LEA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $158.4M | -48% |
| Q2 2026 | $287.8M | +69% |
| Q1 2026 | -$26.5M | +$205.2M |
| Q4 2025 | $281.1M | -42% |
| Q3 2025 | $307M | +508% |
| Q2 2025 | $170.8M | +0.2% |
| Q1 2025 | -$231.7M | -$83.5M |
| Q4 2024 | $488.7M | +30% |
LEA has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA has the edge over LEA on leverage, with a lower net debt burden relative to earnings.
LEA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.3x | Healthy |
| Q2 2026 | 1.2x | Healthy |
| Q1 2026 | 1.3x | Healthy |
| Q4 2025 | 1.2x | Healthy |
| Q3 2025 | 1.2x | Healthy |
| Q2 2025 | 1.3x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.1x | Healthy |
LEA's net debt is about 1.3 years of its operating earnings (EBITDA), about the same as a year ago.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
LEA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 6.0 | Oversold |
LEA's weekly RSI is 37 (neutral) and its Stochastic is 6 (oversold).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
LEA PE vs Consumer Cyclical Sector
| Metric | LEA | Sector median | Relative |
|---|---|---|---|
| PE | 9.5x | 18x | 47% below |
| PE % | 5 | 47 | 42 pts below |
LEA has the edge over BABA on valuation relative to its sector.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
LEA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $117.0 | 7.2% below |
| 20 week MA | $125.3 | 13% below |
| 50 week MA | $126.4 | 14% below |
| 100 week MA | $111.6 | 2.7% below |
| 200 week MA | $120.2 | 9.7% below |
LEA is in a downtrend: it's below all five of its weekly moving averages, and 9.7% below its 200-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
LEA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $138.5 | $159.9 | +15% |
| 2021 | $159.9 | $180.0 | +13% |
| 2022 | $180.0 | $121.9 | -32% |
| 2023 | $121.9 | $141.2 | +16% |
| 2024 | $141.2 | $95.4 | -32% |
| 2025 | $95.4 | $116.9 | +23% |
| 2026 YTD | $116.9 | $108.6 | -7.1% |
LEA has the edge over BABA on returns for 2026, with the stronger performance.